Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

6.1%

2 terminated out of 33 trials

Success Rate

89.5%

+3.0% vs benchmark

Late-Stage Pipeline

42%

14 trials in Phase 3/4

Results Transparency

12%

2 of 17 completed with results

Key Signals

2 with results89% success

Data Visualizations

Phase Distribution

25Total
Not Applicable (8)
P 1 (2)
P 2 (1)
P 3 (2)
P 4 (12)

Trial Status

Completed17
Unknown11
Terminated2
Active Not Recruiting2
Recruiting1

Trial Success Rate

89.5%

Benchmark: 86.5%

Based on 17 completed trials

Clinical Trials (33)

Showing 20 of 20 trials
NCT03935958Not ApplicableActive Not RecruitingPrimary

Curcumin in Kidney Transplant Recipients

NCT06584773Phase 4RecruitingPrimary

Efficacy of a Quadruple Immunosuppressor Regimen With mTOR Inhibitors in Sensitized Kidney Transplant Patients

NCT02843867Active Not RecruitingPrimary

Orientation of the Lymphocyte Response to the Occurrence of Atherosclerotic Complications After Kidney Transplantation

NCT02849899Phase 3UnknownPrimary

Prevention of Diabetes After Transplantation by Vildagliptin in the Early Post-transplant Period

NCT02843763Not ApplicableUnknownPrimary

Study of Specific CD4 Tumors Th1 Responses in Renal Transplant After Occurrence of Cancer

NCT00905957Not ApplicableCompletedPrimary

Transversus Abdominis Plane Block For Renal Transplant Recipients

NCT01602861Phase 4CompletedPrimary

The Effects of Spironolactone on Calcineurin Inhibitor Induced Nephrotoxicity

NCT02540395Not ApplicableCompletedPrimary

Prospective Donor Specific T Response Measurment for IS Minimization in de Novo Renal Transplantation

NCT00167661Phase 1TerminatedPrimary

Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation

NCT03263052CompletedPrimary

Converting Elderly Kidney Transplant Recipients From Tacrolimus to Envarsus to Limit Neurological AE and Improve QOL

NCT03968588Phase 4CompletedPrimary

Standard- Versus Reduced-dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Renal Transplantation

NCT02751099Unknown

Bone and Cardiovascular Disease After Kidney Transplant

NCT02581436Not ApplicableCompletedPrimary

Testing Immunosuppression Threshold in Renal Allografts To Extend eGFR

NCT02515643UnknownPrimary

Contribution of Renal Function to Endothelial Dysfunction in Living Kidney Donors and Transplant Recipients

NCT02843841Not ApplicableUnknownPrimary

Polyclonal Antilymphocyte Globulin (ATG) & Intestinal Immune Barrier After Kidney Transplantation

NCT02513602Unknown

Osseointegrated Dental Implants in Kidney Transplanted Patients

NCT02857907CompletedPrimary

Anti-thymocyte Globulin-induced Immune Senescence

NCT02841111CompletedPrimary

Old Red Blood Cell In Renal Transplantation

NCT02683291Phase 4CompletedPrimary

Sirolimus Associated With Tacrolimus at Low Doses in Elderly Kidney Transplant Patients

NCT01744067Phase 4CompletedPrimary

The Effects of Omega-3 Fatty Acids in Renal Transplantation

Scroll to load more

Research Network

Activity Timeline